PETROS PHARMACEUTICALS INC's ticker is and the CUSIP is 71678J209. A total of 17 filers reported holding PETROS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,499 | -70.2% | 3,274 | -3.6% | 0.00% | – |
| Q1 2024 | $5,025 | -61.0% | 3,395 | -62.8% | 0.00% | – |
| Q4 2023 | $12,869 | +192.6% | 9,127 | +259.0% | 0.00% | – |
| Q3 2023 | $4,398 | -14.9% | 2,542 | -0.2% | 0.00% | – |
| Q2 2023 | $5,168 | +172166.7% | 2,546 | +10.2% | 0.00% | – |
| Q1 2023 | $3 | +200.0% | 2,310 | +359.2% | 0.00% | – |
| Q4 2022 | $1 | – | 503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 70,256 | $32 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 54 | $25 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,370 | $13,939 | 0.00% |
| EMFO, LLC | 1,000 | $458 | 0.00% |
| BlackRock Inc. | 16,510 | $7,553 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 53,876 | $24,648 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,274 | $1,499 | 0.00% |
| MORGAN STANLEY | 19 | $9 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 313 | $136 | 0.00% |